Literature DB >> 17997135

Staphylococcus aureus of phage type 187 isolated from people occurred to be a genes carrier of eneterotoxin C and toxic shock syndrome toxin-1 (TSST-1).

Lidia Piechowicz1, Katarzyna Garbacz, Janusz Galiński.   

Abstract

The aim of this study was to examine the genotype properties of Staphylococcus aureus of phage type 187 strains that constitute a separate group among the strains of S. aureus. Sixteen strains were collected from the hospital patients (n=12) and the healthy carriers (n=4) in 13 medical centres in Poland during 1991 and 2005. Biotyping, antibiotic susceptibility, phage typing, detection the genes of enterotoxins and toxic shock syndrome toxin, genotyping of chromosomal DNA by pulsed-field gel electrophoresis (PFGE), also amplification and restriction analysis of the coagulase (coa) and the protein A genes (spa) (PCR/restriction fragment length polymorphism (RFLP)) was tested. The results of this study showed that all staphylococcus of phage type 187 belonged to the human biotype (A) and appeared to be sensitive to all of the tested antibiotics, including methicillin (MSSA). Finding out the toxin genes showed that almost all of them (93.8%) had the enterotoxin C gene (sec) and TSST-1 gene (tst). The PFGE typing proved that the phage type 187 strains (except for one) constitute one PFGE type. These results and the identical restriction patterns in the PCR/RFLP method, also the same biotype, sensitivity to antibiotics and the presence genes of the same type of toxins confirmed that the phage type 187 strains constitute one clone within our country. Additionally, the fact that almost all of them have the enterotoxin genes and tst gene allows to consider them the strains of potentially high virulence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17997135     DOI: 10.1016/j.ijheh.2007.06.010

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  5 in total

1.  In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin.

Authors:  Evgeny A Idelevich; Christof von Eiff; Alexander W Friedrich; Domenico Iannelli; Guoqing Xia; Georg Peters; Andreas Peschel; Ingrid Wanninger; Karsten Becker
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

2.  Staphylococci isolated from carriage sites and infected sites of dogs as a reservoir of multidrug resistance and methicillin resistance.

Authors:  Katarzyna Garbacz; Sabina Żarnowska; Lidia Piechowicz; Krystyna Haras
Journal:  Curr Microbiol       Date:  2012-10-26       Impact factor: 2.188

3.  Phage type 187 as a separate subunit MboI restriction site within the Staphylococcus aureus species.

Authors:  Katarzyna Garbacz; Lidia Piechowicz
Journal:  Curr Microbiol       Date:  2013-01-30       Impact factor: 2.188

4.  Biosynthesis of the unique wall teichoic acid of Staphylococcus aureus lineage ST395.

Authors:  Volker Winstel; Patricia Sanchez-Carballo; Otto Holst; Guoqing Xia; Andreas Peschel
Journal:  mBio       Date:  2014-04-08       Impact factor: 7.867

5.  In Vitro Activity of the Bacteriophage Endolysin HY-133 against Staphylococcus aureus Small-Colony Variants and Their Corresponding Wild Types.

Authors:  Nina Schleimer; Ursula Kaspar; Dennis Knaack; Christof von Eiff; Sonja Molinaro; Holger Grallert; Evgeny A Idelevich; Karsten Becker
Journal:  Int J Mol Sci       Date:  2019-02-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.